It’s time pharma ramped up its focus on digital transformation

Pic by Patrick Untersee on Unsplash

The pharmaceutical industry was less ready for digital transformation in 2021 than it was in 2018, partly due to the strain of responding to COVID’s digital demands.

That’s one of the conclusions from our latest piece of research, The State Of Digital Excellence In The Global Pharmaceutical Industry, which presents a comprehensive picture of how pharma fared in the last six years.

Most recently, it is clear that COVID-19 did catalyse digital transformation across the industry, but it also seems to have brought an element of paralysis as more local and regional commercial leaders got involved.